Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients

clot
deep vein thrombosis
dalteparin
deep venous thrombosis of lower extremity
venous thromboembolism
  • 0 views
  • 19 Apr, 2022
  • 1 location
WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Cancer patients that develop blood clots are treated with low molecular weight heparin injections (LMWH). One kind of these LMWHs, dalteparin, has its dose determined based on a patient's weight

clot
deep vein thrombosis
carcinoma
primary cancer
dalteparin
  • 136 views
  • 05 Mar, 2022
  • 5 locations
Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

The study aims to describe the biochemical coagulation profile and investigate the effect of Low molecular weight heparin and Apixaban on this profile in patients with nephrotic syndrome.

  • 0 views
  • 30 Apr, 2021
  • 1 location
A Randomised Control Trial Comparing Functional Outcomes for Navigated Kinematically Aligned TKR Versus Navigated Mechanically Aligned TKR (MaKKRO)

The overall aim of the study is to compare navigated kinematically aligned total knee replacements (KA TKR) with navigated mechanically aligned TKR (MA TKR) in terms of function and ROM The objectives are therefore: To compare the functional outcomes of KA TKR versus MA TKR performed using navigation technique To …

Accepts healthy volunteers
  • 1 views
  • 12 May, 2022
  • 1 location
Pharmacogenomics of Heparin-Induced Thrombocytopenia (PHIT)

The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin …

  • 14 views
  • 23 Feb, 2022
  • 1 location